Cargando…
Fundamentals of Rhenium-188 Radiopharmaceutical Chemistry
The β(−) emitter, rhenium-188 ((188)Re), has long been recognized as an attractive candidate for targeted cancer radionuclide therapy (TRNT). This transition metal shares chemical similarities with its congener element technetium, whose nuclear isomer technetium-99m ((99m)Tc) is the current workhors...
Autores principales: | Kleynhans, Janke, Duatti, Adriano, Bolzati, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9921938/ https://www.ncbi.nlm.nih.gov/pubmed/36771153 http://dx.doi.org/10.3390/molecules28031487 |
Ejemplares similares
-
The determination of the radiochemical purity of Actinium-225 radiopharmaceuticals: a conundrum
por: Kleynhans, Janke, et al.
Publicado: (2022) -
Rhenium-188 Labeled Radiopharmaceuticals: Current Clinical Applications in Oncology and Promising Perspectives
por: Lepareur, Nicolas, et al.
Publicado: (2019) -
Monoclonal Antibodies Radiolabeling with Rhenium-188 for Radioimmunotherapy
por: Uccelli, Licia, et al.
Publicado: (2017) -
The DOTA macrocyclic cavity in metallic radiopharmaceuticals: Mythology or reality?
por: Duatti, Adriano
Publicado: (2023) -
Rhenium 188: The Poor Man's Yttrium
por: Shinto, Ajit
Publicado: (2017)